What is Esper Bionics?
Esper Bionics operates at the intersection of advanced engineering and human-centric healthcare. Headquartered in New York with critical production and design infrastructure based in Kyiv, the company specializes in the development and manufacturing of sophisticated bionic prosthetics. By integrating cutting-edge technology with ergonomic design, Esper Bionics aims to restore mobility and improve the quality of life for individuals requiring prosthetic assistance. The company's market position is defined by its commitment to technical excellence and its ability to navigate the complex regulatory and manufacturing landscapes inherent to the medical device industry.
How much funding has Esper Bionics raised?
Esper Bionics has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2024): $5M with participation from EBRD, U! Ventures, and YZR Capital
Key Investors in Esper Bionics
EBRD
EBRD is a partner in demolition and earthworks, offering services including material acceptance and recycling construction materials while promoting a sustainable cycle in waste management.
U! Ventures
UVENTURES is a team within the LOBBE Group that drives innovative business models, corporate ventures, and digital transformation by connecting founders with established industrial strengths.
YZR Capital
YZR Capital is a Munich-based venture capital firm specializing in early-stage HealthTech, providing capital and strategic guidance to companies in digital health and TechBio.
What's next for Esper Bionics?
Looking ahead, the strategic deployment of the $5M will likely focus on scaling manufacturing capabilities and enhancing the technological sophistication of their prosthetic product line. As the company transitions through this major enterprise-level funding phase, the focus will shift toward optimizing supply chain logistics and expanding market penetration. The involvement of specialized HealthTech investors suggests a roadmap that prioritizes clinical validation and the integration of next-generation diagnostic or adaptive features into their existing prosthetic portfolio. This growth trajectory positions Esper Bionics to become a dominant player in the global assistive technology market, provided they maintain their current pace of innovation and operational execution.
See full Esper Bionics company page
